Published in Stat Appl Genet Mol Biol on February 04, 2009
A pathway-based classification of human breast cancer. Proc Natl Acad Sci U S A (2010) 3.30
Diagnosis of partial body radiation exposure in mice using peripheral blood gene expression profiles. PLoS One (2010) 1.07
Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans. PLoS One (2013) 0.99
Integrating factor analysis and a transgenic mouse model to reveal a peripheral blood predictor of breast tumors. BMC Med Genomics (2011) 0.91
Latent factor analysis to discover pathway-associated putative segmental aneuploidies in human cancers. PLoS Comput Biol (2010) 0.88
Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence. Oncogene (2011) 0.83
Use of gene expression and pathway signatures to characterize the complexity of human melanoma. Am J Pathol (2011) 0.81
Metaprotein expression modeling for label-free quantitative proteomics. BMC Bioinformatics (2012) 0.81
Bayesian learning from marginal data in bionetwork models. Stat Appl Genet Mol Biol (2011) 0.81
AN INTEGRATIVE ANALYSIS OF CANCER GENE EXPRESSION STUDIES USING BAYESIAN LATENT FACTOR MODELING. Ann Appl Stat (2009) 0.79
Usefulness of two-dimensional strain echocardiography to predict segmental viability following acute myocardial infarction and optimization using bayesian logistic spatial modeling. Am J Cardiol (2009) 0.77
Molecular portraits of human breast tumours. Nature (2000) 94.14
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell (2006) 27.36
Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res (2005) 22.62
Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature (2005) 19.56
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell (2006) 16.05
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A (2005) 13.54
Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A (2001) 13.30
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res (2005) 8.73
c-MYC: more than just a matter of life and death. Nat Rev Cancer (2002) 6.73
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med (2006) 6.04
High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics. J Am Stat Assoc (2008) 3.92
Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet (2003) 3.78
Myc pathways provoking cell suicide and cancer. Oncogene (2003) 3.49
GATHER: a systems approach to interpreting genomic signatures. Bioinformatics (2006) 3.22
Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res (2005) 2.63
Function of the c-Myc oncogenic transcription factor. Exp Cell Res (1999) 2.11
Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res (2006) 1.72
Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem (2004) 1.27
Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis. Cancer Res (2008) 1.26
The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxid Redox Signal (2007) 1.20
Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells. Cancer Res (1999) 1.00
Gene expression phenotypes of oncogenic signaling pathways. Cell Cycle (2003) 0.95
Nestin is expressed in basal-like and triple negative breast cancers. J Clin Pathol (2008) 0.91
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature (2005) 19.56
Gene expression predictors of breast cancer outcomes. Lancet (2003) 6.99
Retracted A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med (2006) 6.69
Retracted An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. J Clin Oncol (2007) 5.77
High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics. J Am Stat Assoc (2008) 3.92
Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet (2003) 3.78
Statistical mixture modeling for cell subtype identification in flow cytometry. Cytometry A (2008) 3.06
Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc Natl Acad Sci U S A (2004) 2.74
Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res (2005) 2.63
Understanding GPU Programming for Statistical Computation: Studies in Massively Parallel Massive Mixtures. J Comput Graph Stat (2010) 2.38
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res (2005) 2.37
Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 2.23
A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Mol Cell (2009) 2.22
Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng (2006) 1.86
Image segmentation and dynamic lineage analysis in single-cell fluorescence microscopy. Cytometry A (2010) 1.75
Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res (2006) 1.72
The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet (2008) 1.60
Spatial Mixture Modelling for Unobserved Point Processes: Examples in Immunofluorescence Histology. Bayesian Anal (2009) 1.58
Genomic prediction of locoregional recurrence after mastectomy in breast cancer. J Clin Oncol (2006) 1.57
Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet (2003) 1.51
Hierarchical modeling for rare event detection and cell subset alignment across flow cytometry samples. PLoS Comput Biol (2013) 1.35
Lactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoA. PLoS Genet (2010) 1.34
Distinctions in the specificity of E2F function revealed by gene expression signatures. Proc Natl Acad Sci U S A (2005) 1.34
Origin of bistability underlying mammalian cell cycle entry. Mol Syst Biol (2011) 1.32
Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol (2004) 1.29
Energetics and biomechanics as determining factors of swimming performance: updating the state of the art. J Sci Med Sport (2009) 1.28
Prediction and uncertainty in the analysis of gene expression profiles. In Silico Biol (2002) 1.27
Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res (2003) 1.26
Bayesian analysis of matrix normal graphical models. Biometrika (2009) 1.18
Seagulls of the Berlengas natural reserve of Portugal as carriers of fecal Escherichia coli harboring CTX-M and TEM extended-spectrum beta-lactamases. Appl Environ Microbiol (2008) 1.15
An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer. BMC Genomics (2008) 1.14
Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci U S A (2005) 1.09
Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice. Biomaterials (2006) 1.08
Efficient Classification-Based Relabeling in Mixture Models. Am Stat (2011) 1.06
Gene expression profiling for prediction of clinical characteristics of breast cancer. Recent Prog Horm Res (2003) 1.04
Bayesian analysis of binary prediction tree models for retrospectively sampled outcomes. Biostatistics (2004) 1.02
Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Int J Radiat Oncol Biol Phys (2006) 0.97
Cross-study projections of genomic biomarkers: an evaluation in cancer genomics. PLoS One (2009) 0.96
Gene expression phenotypes of oncogenic signaling pathways. Cell Cycle (2003) 0.95
Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies. Stat Appl Genet Mol Biol (2013) 0.95
Optimization of a highly standardized carboxyfluorescein succinimidyl ester flow cytometry panel and gating strategy design using discriminative information measure evaluation. Cytometry A (2010) 0.92
Individual preformed titanium meshes for orbital fractures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 0.91
Improvement of vascularization of PLGA scaffolds by inosculation of in situ-preformed functional blood vessels with the host microvasculature. Ann Surg (2008) 0.88
Bayesian Weibull tree models for survival analysis of clinico-genomic data. Stat Methodol (2008) 0.87
Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80. N Engl J Med (2011) 0.87
Selection Sampling from Large Data Sets for Targeted Inference in Mixture Modeling. Bayesian Anal (2010) 0.87
Computation of steady-state probability distributions in stochastic models of cellular networks. PLoS Comput Biol (2011) 0.86
Adaptive Mixture Modelling Metropolis Methods for Bayesian Analysis of Non-linear State-Space Models. J Comput Graph Stat (2010) 0.86
Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963). Chronobiol Int (2011) 0.85
Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter? J Surg Oncol (2011) 0.85
Productive work and employment for persons with traumatic brain injury: what have we learned after 20 years? J Head Trauma Rehabil (2005) 0.85
Vascularization and biocompatibility of scaffolds consisting of different calcium phosphate compounds. J Biomed Mater Res A (2008) 0.85
Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer. Cancer (2013) 0.84
Proteomic characterization of vanA-containing Enterococcus recovered from Seagulls at the Berlengas Natural Reserve, W Portugal. Proteome Sci (2010) 0.83
Bayesian learning from marginal data in bionetwork models. Stat Appl Genet Mol Biol (2011) 0.81
eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development. Oncol Rep (2009) 0.81
AN INTEGRATIVE ANALYSIS OF CANCER GENE EXPRESSION STUDIES USING BAYESIAN LATENT FACTOR MODELING. Ann Appl Stat (2009) 0.79
Influence of oral hygiene in patients with fixed appliances in the oral carriage of antimicrobial-resistant Escherichia coli and Enterococcus isolates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.79
Bayesian Learning in Sparse Graphical Factor Models via Variational Mean-Field Annealing. J Mach Learn Res (2010) 0.78
Bone repair by cell-seeded 3D-bioplotted composite scaffolds made of collagen treated tricalciumphosphate or tricalciumphosphate-chitosan-collagen hydrogel or PLGA in ovine critical-sized calvarial defects. J Biomed Mater Res B Appl Biomater (2010) 0.78
Clonal lineages, antibiotic resistance and virulence factors in vancomycin-resistant enterococci isolated from fecal samples of red foxes (Vulpes vulpes). J Wildl Dis (2011) 0.78
Model-controlled flooding with applications to image reconstruction and segmentation. J Electron Imaging (2012) 0.77
The role of NT-proBNP as a prognostic marker in pulmonary hypertension. Chest (2006) 0.77
DIG--a system for gene annotation and functional discovery. Bioinformatics (2005) 0.77
Antimicrobial resistance and class I integrons in Salmonella enterica isolates from wild boars and Bísaro pigs. Int Microbiol (2011) 0.77
[Ossiculoplasty with titanium prosthesis]. Acta Otorrinolaringol Esp (2011) 0.76
Genetic characterization of vancomycin-resistant enterococci isolates from wild rabbits. J Basic Microbiol (2009) 0.76
Of cardiovascular illness and diversity of biological response. Trends Cardiovasc Med (2008) 0.76
Polymorphism of the storage proteins in Portuguese rye (Secale cereale L.) populations. Hereditas (2012) 0.76
Accelerated angiogenic host tissue response to poly(L-lactide-co-glycolide) scaffolds by vitalization with osteoblast-like cells. Tissue Eng Part A (2010) 0.76
Report from a consensus meeting: response to chemoradiotherapy in rectal cancer - predictor of cure and a crucial new choice for the patient: on behalf of the Champalimaud 2014 Faculty for 'Rectal cancer: when NOT to operate'. Colorectal Dis (2014) 0.76
The need for national registries in rare diseases. Am J Respir Crit Care Med (2006) 0.75
An overview of genomic data analysis. Surgery (2004) 0.75
Development of a high-speed, multiplexed sample-delivery instrument for LC-MS/MS bioanalysis. Bioanalysis (2012) 0.75
Digitally Assisted Versus Conventional Home-Based Rehabilitation After Arthroscopic Rotator Cuff Repair: A Randomized Controlled Trial. Am J Phys Med Rehabil (1) 0.75
Diffuse micronodules with spontaneous resolution. Am J Respir Crit Care Med (2011) 0.75
The influence of storage condition and duration on the resistance to fracture of different fiber post systems. Am J Dent (2009) 0.75
Long-term clinical and radiological postoperative outcomes after an interspinous microdecompression of degenerative lumbar spinal stenosis. Spine (Phila Pa 1976) (2014) 0.75
Calvaria bone chamber--a new model for intravital assessment of osseous angiogenesis. J Biomed Mater Res A (2011) 0.75